ISPOR's Short Course Program Is Now Virtual

The renowned ISPOR Short Course Program is now being offered virtually. The program is designed to enhance knowledge and techniques in core health economics and outcomes research (HEOR) topics as well as emerging trends in the field. Taught by expert faculty, short courses topics are offered across 7 topical tracks and range in skill level from introductory to experienced.

Upcoming Virtual Short Courses

Expand your HEOR knowledge from the safety and comfort of your home or office. ISPOR's expert short course faculty are presenting the same curriculum that has historically been offered at ISPOR in-person events through an interactive virtual experience. The courses are not recorded so attendance in the live-broadcast is important. These hand-picked virtual courses, along with their electronic course books, provide a solid foundation in essential methodologies and emerging issues.

 

10-11 March 2021: US PAYERS - UNDERSTANDING THE HEALTHCARE SYSTEM

LEVEL - Introduction
TRACK - Health Policy & Regulatory
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours/day

Wednesday, 10  March | 2 hours of content
09:00-11:00 Eastern Standard Time (EST)
14:00-16:00 Greenwich Mean Time (GMT)
15:00-17:00  Central European Time (CET)

Thursday, 11 March | 2 hours of content
09:00-11:00 Eastern Standard Time (EST)
14:00-16:00 Greenwich Mean Time (GMT)
15:00-17:00  Central European Time (CET)

Basic Schedule:
Class Time: 2 hours daily

Click for time zone conversion

DESCRIPTION

The US healthcare system is a hybrid system that provides access to care via various channels and means. It can be categorized as governmental systems (Medicare, Medicaid, Veterans Health Administration, and Department of Defense, etc), private markets (privately sponsored regional and national health plans), and providers assuming responsibility for access and coverage via mechanisms such as Provider Networks, Integrated Delivery Networks (IDNs), Accountable Care Organizations (ACOs), etc. These elements are quite heterogeneous and characterized by different coverage and access mechanisms. This introductory course will cover the roots of the current US system, its evolutionary process, and the consequent independence of these different parts of the system. The focus will be on value and affordability as defined by cost, access, and quality. While all hold value and affordability as important goals, the different stakeholders take various perspectives and define these goals differently. This results in different objectives, incentives, and principles under which they operate. The intent of this course is to better understand the characteristics of the different parts of the US healthcare system and the role of various decision-makers within it. The course will cover their structure, scope, processes, and perspectives as well as their approach to balancing access, costs, and quality. The course will also cover how industry and others produce evidence to support access and reimbursement decisions and how the evidence is used by decision-makers.

This session will facilitate the increased level of understanding of these disparate systems and emphasize the need to effectively communicate evidence to various access decision-makers to support and enhance evidence-driven decision making on value and affordability. The course will focus on how these entities differ in perspectives, coverage mechanisms, and the means and evidence they use to define and achieve both value (access and quality) and affordability. This course is designed for those having limited experience in understanding the structure of the US Healthcare system, including its various subsystems and how they operate.



FACULTY MEMBERS
Finn Børlum Kristensen, MD, PhD
Professor
University of Southern Denmark
Hilleroed, Denmark

 

Jessica Daw, PharmD, MBA
Vice President, Pharmacy
Sentara Health Plans
Virginia Beach, VA, USA

James Murray, PhD
Research Fellow
Eli Lilly and Company
Carmel, IN, USA

Laura Pizzi, PharmD, MPH, RPh
Professor & Director
Health Outcomes, Policy, and Economics (HOPE) Program
Rutgers University
Piscataway, NJ, USA 

 

24-25 March 2021: Understanding Survival Modelling with Application to HTA

LEVEL - Intermediate
TRACK - Methodological & Statistical Research
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours/day

Wednesday, 24  March | 2 hours of content
10:00-12:00 Eastern Standard Time (EDT)
14:00-16:00 Greenwich Mean Time (GMT)
15:00-17:00  Central European Time (CET)

Thursday, 25 March | 2 hours of content
10:00-12:00 Eastern Standard Time (EDT)
14:00-16:00 Greenwich Mean Time (GMT)
15:00-17:00  Central European Time (CET)

Basic Schedule:
Class Time: 2 hours daily

Click for time zone conversion

DESCRIPTION

Time-to-event (survival) analysis is an important element in many economic analyses of health care technologies. This is particularly true in oncology given the requirement to estimate lifetime costs and outcomes (i.e. extrapolate) beyond the follow-up typically observed in clinical trials. Cost-effectiveness estimates can be sensitive to the methods applied in modelling survival data. Recommendations for selecting a parametric survival model have been recently been published; following a review of extrapolation modelling in National Institute for Health and Care Excellence (NICE) technology appraisals.

The purpose of this course is to provide participants with an understanding of the fundamentals of survival analysis and key issues to be considered when comparing alternative survival models for inclusion in cost-effectiveness analysis. This will include an understanding of the differences between partitioned survival and Markov-based approaches. The course runs 2 days for 2 hrs/day.



FACULTY MEMBERS
Andrew Briggs, DPhil
Professor of Health Economics
London School of Hygiene & Tropical Medicine
London, UK

Andrew Davies, MSc
Senior Health Economist
University of Glasgow
Glasgow, UK

Jim Lewsey, PhD
Reader in Medical Statistics
University of Glasgow 
Glasgow, UK

 

31 March - 1 April 2021: Market Access & Value Assessment of Medical Devices

LEVEL - Intermediate
TRACK - Health Policy & Regulatory
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours/day

Wednesday, 31  March | 2 hours of content
09:00-11:00 Eastern Standard Time (EDT)
14:00-16:00 Greenwich Mean Time (GMT)
15:00-17:00  Central European Time (CEST)

Thursday, 1 April | 2 hours of content
09:00-11:00 Eastern Standard Time (EDT)
14:00-16:00 Greenwich Mean Time (GMT)
15:00-17:00  Central European Time (CEST)

Basic Schedule:
Class Time: 2 hours daily

Click for time zone conversion

DESCRIPTION

 

The focus of this course will be on understanding the leading trends and core determinants of market access amongst European Union (EU) healthcare systems and along with leading concepts in USA healthcare systems relevant to medical devices (eg, diagnosis-related groups (DRGs), inpatient versus outpatient), implicit value drivers of medical devices, the stakeholder organizations necessary to engage in order to obtain medical device funding/reimbursement and adoption, and the healthcare system pathways through which medical devices can be implemented. The course will conclude with a primer on performance-based risk-sharing agreements and the latest trends in value-based procurement in the EU. Market access for medical devices is an evolving, multi-faceted, and multi-stakeholder journey that requires dedicated knowledge. Experience in launching pharmaceutical products can present both challenges and opportunities for medical device companies, as the pathways, evidence requirements, and value domains are materially different. This course will attempt to demystify the medical device landscape and help all stakeholders ensure that appropriate patients benefit from innovation in the medical device space through improving participants’ awareness of marketplace trends and needs to demonstrate clinical and economic value.

This course is designed for those with an intermediate knowledge of medical devices and their market access pathways. 



FACULTY MEMBERS

Stephen A. Hull, MHS
>Principal & Founder
Hull Associates LLC
Rockland, MA, USA

Richard Charter, MSc
Vice President - EU & Asia Pacific MedTech
Market Access, Alira Health
Basel, BS, Switzerland

Rachele Busca, MBA, MS
EMEA Leader Health Economics
W. L. Gore & Associates
Verona, Italy

 

 

28-29 April 2021: Introduction to Patient-Reported Outcomes Assessment: Instrument Development & Evaluation

 

LEVEL - Introductory
TRACK - Patient Centered Research
LENGTH - 4 Hours | Course runs 2 consecutive days, 2 hours each day

 

Wednesday, 28  April | 2 hours of content
8:00AM-10:00AM (EDT) Eastern Daylight  Time
12:00PM-2:00PM (UTC) Coordinated Universal Time
2:00PM-4:00PM (CEST) Central European Standard Time


Thursday, 29  April | 2 hours of content
8:00AM-10:00AM (EDT) Eastern Daylight  Time
12:00PM-2:00PM (UTC) Coordinated Universal Time
2:00PM-4:00PM (CEST) Central European Standard Time

 

Basic Schedule:
Class Time: 2 hours daily

Click for time zone conversion

DESCRIPTION

Patient-reported outcome (PRO) measures are used to quantify the impact of interventions from the patients' perspective. This course is designed to familiarize participants with the range and scope of what PRO measures are used for, how they are developed and evaluated, what they measure, and how PRO data can be used in clinical trial, or clinical care applications. We will discuss the properties of a good PRO measure. Participants will be able to identify steps researchers generally go through in order to develop and test a new PRO measure, including item generation, qualitative cognitive testing, and quantitative psychometric evaluation. 

This is an entry level course which assumes only a passing familiarity with patient-reported outcomes. 



FACULTY MEMBERS

Theresa Coles, PhD
Assistant Professor
Duke University
Durham, North Carolina, USA

 

 

26-27 May 2021: Tools for Reproducible Real-World Data Analysis

 

LEVEL - Intermediate
TRACK - Real World Data & Information Systems
LENGTH - 4 Hours | Course runs 2 consecutive days, 2 hours each day

 

Wednesday, 26  May | 2 hours of content
9:00AM-11:00AM (EDT) Eastern Daylight  Time
1:00PM-3:00PM (UTC) Coordinated Universal Time
3:00PM-5:00PM (CEST) Central European Standard Time


Thursday, 27 May | 2 hours of content
9:00AM-11:00AM (EDT) Eastern Daylight  Time
1:00PM-3:00PM (UTC) Coordinated Universal Time
3:00PM-5:00PM (CEST) Central European Standard Time

 

Basic Schedule:
Class Time: 2 hours daily

Click for time zone conversion

DESCRIPTION

This course will focus on the concepts and tools of reproducible research and reporting of modern data analyses. The need for more reproducible tools in health economics and outcomes research is growing rapidly as analyses of real world data become more frequent, involve larger datasets, and employ more complex computations. This course will cover the principles of structuring and organizing a modern data analysis, literate statistical analysis tools, formal version control, software testing and debugging, and developing reproducible reports. Numerous real-world examples and an interactive class exercise will be used to reinforce the concepts and tools introduced. Participants who wish to gain hands-on experience are required to bring their laptops with R and RStudio installed. 



FACULTY MEMBERS

Blythe Adamson, PhD, MPH
Principal Quantitative Scientist
Flatiron Health
New York, NY, USA

Carrie Bennette, PhD, MPH
Principle Methodologist
Flatiron Health
Seattle, WA, USA

Joshua Kraut, MS
Senior Data Insights Engineer
Flatiron Health
Seattle, WA, USA

Registration Rates for ISPOR Short Courses

8 Hour | 2 Day or 4 Day  Short CourseNon-member
Rate
Member Rate
Standard $680$510
Clinical Practitioners$510$385
Full-Time Government and Academia$475$360
Patient Representative$340$225
Full-Time Students (must provide current enrollment docs)$200$160
  
4 Hour | 1 or 2 Day Short CourseNon-memberMember Rate
Standard$340$255
Clinical Practitioners$255$190
Full-Time Government and Academia
$240$180
Patient Representative$170$130
Full-Time Students (must provide current enrollment docs)$100$80

The cancellation date for short courses is 2 weeks before the course. All cancellation requests must be made in writing and emailed to ISPOR Registration. A $50.00 cancellation fee applies. After the 2 week period no refund can be provided.

Additional Short Course Program Details

Short Course Tracks

ISPOR short courses are offered across the following topical tracks:

  • Economic Evaluation
  • Methodological & Statistical Research
  • Study Approaches
  • Real World Data & Information Systems
  • Patient-Centered Research
  • Health Policy & Regulatory
  • Health Technology Assessment

Short Course Core Curriculum

ISPOR short course core curriculum is defined as essential curriculum for professional success in the HEOR field; courses/topic areas that are offered at all conferences and the building blocks of a fundamental curriculum that can be applied to future educational programs/offerings.

  • Economic Evaluation
    • Introduction to Health Economics and Outcomes Research
    • Statistical Methods for Health Economics and Outcomes Research
    • Budget Impact Analysis I – A 6-Step Approach
  • Methodology & Statistical Methods
    • Introduction to Modeling Methods
  • Study Approaches
    • Introduction to the Design & Database Analysis of Observational Studies of Treatment Effects
    • Meta-analysis & Systematic Literature Review
    • Network Meta-Analysis
  • Patient-Centered Research
    • Introduction to Patient-Reported Outcomes
    • Utility Measures
  • Health Policy & Regulatory
    • Elements of Pharmaceutical/Biotech Pricing
    • Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products
    • Global Payers/US Payers
  • Health Technology Assessment
    • Introduction to Health Technology Assessment

 

Need More Information or Have Questions?

Contact us for more information on ISPOR education and training.

Contact Us

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×